Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps

Bartłomiej Matejko 1, Małgorzata Grzanka 1, Beata Kieć-Wilk 1, Maciej T Małecki 1, Tomasz Klupa 1
1 - Department and Chair of Metabolic Diseases, Jagiellonian University, Krakow, Poland
Ann Agric Environ Med
2013; 20 (1):
ICID: 1041690
Article type: Original article
 
 
Introduction and Objective. The ability to perceive the symptoms of hypoglycemia during the early decrease in plasma glucose concentration may be critical for the safety of T1DM patients treated with intensive insulin therapy, including those treated with continuous subcutaneous insulin infusion (CSII). In the presented observational study an attempt was made to asses clinical factors that might affect subjective awareness of hypoglycemia in CSII-treated T1DM patients, with special attention to factors specific for this mode of treatment.
Materials and Methods. For the purpose of the study, data of 110 CSII-treated T1DM patients were collected (78 females and 32 males). The records were analyzed from glucose meters (200-300 measurements/download, depending on meter type) and insulin pumps (total insulin dose, basal/bolus ratio, number of boluses/day, bolus calculator and dual wave/square bolus usage, continuous glucose monitoring data) from the last 3 years.
Results. It was found that the level of subjective hypoglycemia perception inversely correlated with the number of hypoglycemic episodes per 100 measurements, age, duration of diabetes, time on insulin pump, and positively correlated with mean glycemia (n = 98; r = 0.22; p = 0.0286). With respect to CSII-related factors, hypoglycemia perception inversely correlated with the percentage of basal insulin (n = 106; r = -0.20; p = 0.0354). In stepwise regression analysis, independent predictors for impaired hypoglycemia perception were: age β = -0.29 (p = 0.023), duration of diabetes β = -0.24 (p = 0.029) and number of the hypoglycemia episodes for 100 measurements β = -0.33 (p = 0.0005).
Conclusions. Risk factors for impaired hypoglycemia perception in CSII-treated patients include those identified previously for the general population of T1DM individuals. In addition, the presented results suggest that a higher basal/bolus ratio may lead to impairment of the ability to perceive early symptoms of hypoglycemia.
PMID 23540230 - click here to show this article in PubMed
  FULL TEXT STATS

Recommend this article to:

Name:
E-mail:
From:
Language:


Related articles in IndexCopernicus™
     hypoglycemia perception [0 related records]
     diabetes [966 related records]
     continuous subcutaneous insulin infusion (CSII) [1 related records]
     insulin pump [7 related records]



 

Related articles

Z Bogucki,
 Current views on the dental implant treatmen...
 Diabetes is a systemic disease affecting people, regardless of their race and their age. Unhealthy lifestyle, lack of physical activity and obesity, in particular, predispose to an elevated risk of this disease. The effects of diabetes can also...
ABSTRACT
Z Baramesipour, M Nasirian,
The Effectiveness of Dialectical Behavioral Therap...
Objective: Diabetes is a chronic disease causing not only somatic complications like hyperglycemia, but also increased psychological consequences and impaired psychological well-being in diabetics. Various psychological treatments have been applied s...
ABSTRACT
, ,
The Effect of Educational Interventions on Glycemi...
Background: Diabetes mellitus is a chronic disease with many serious complications. Objectives: The present study aimed to assess the effect of educational interventions on glycemic control represented by changes in glycated hemoglobin (HbA1c) lev...
ABSTRACT